"It is not the strongest of the species that survives, nor the most intelligent, but the one most responsive to change." Charles Darwin
Introduction
Alfred Tauber proposed that "…'immunity' may be a semantic trap that has confined our understanding of the immune system to only a narrow segment of defensive, aggressive functions" (1) . Macfarlane Burnet suggested first regarding the evolutionary origin of adaptive immunity related to processes other than defense against pathogenic microorganisms (2) .
Satisfactory answers have not been available to explain 'why invertebrates including more than two million species in more than 20 phyla use only germline encoded innate immunity', or 'why vertebrates reject any allogeneic or xenogeneic transplanted tissue'. Rinkevich, then challenged the tacit assumptions and dogma that evolution of the immune system is pathogenically directed (3) . He proposed that immunity developed as a surveillance operation to purge nascent selfish cells. Such cells could be isogeneic tumors from the host or transmissible allogeneic cells from kin organisms establishing natural chimerism that littered the soma and the germline by conspecific alien cells. According to Rinkevich the primary role of the vertebrate immune defense is to combat these parasitic events and preserve the individual homogeneity. Somatic compatibility systems that deter genotypes from being contaminated by maladapted alien genotypes might be the origin of immunity (4).
Defense against pathogens, which are xenogeneic aliens appeared later in evolution.
Some current examples of parasitic allogeneic cells are instructive. Canine transmissible venereal tumor (CTVT) is a transmissible cancer allograft that rapidly spreads naturally in dogs worldwide (5) . CTVT may have first arisen within a genetically isolated population of early dogs whose limited genetic diversity facilitated the escape of cancer from Bakacs et al.
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February 28 th 2016 3 the immune surveillance system of the host. The Tasmanian devil facial tumor disease (DFTD) is another highly aggressive cancer allograft presenting a serious extinction risk for the Tasmanian devil population (6) . DFTD arose in an island population with low genetic diversity. It seems that populations with limited genetic diversity may be particularly susceptible to the emergence and spread of transmissible cancers. This way, transmissible allogeneic tumors might have contributed to the evolutionary force shaping the class I immune surveillance system (7).
Based on the complementarity theorem of Dillon and Root-Bernstein (8) (9), we proposed that individual integrity can be preserved from parasitism with a limited repertoire.
This is achieved by a homeostatic coupled system via internal dialogue between the positively selected, low affinity complementary T cells and host cells (10) (11) . The role of regulatory T Cells (Foxp3+ Tregs) seems to be the closest analogy to the role of homeostatic T cells in our model, which is described in more details in (11) .
The thrust of this paper is a fresh approach to reconsider the evolutionary role of viruses with respect to cancer over millions of years for adaptation and survival. The viruses are not just hostile invaders, but the molecular biologic tools of "Nature's genetic engineering laboratory" that have been influencing and regulating key aspects of our biology (12) .
Following Tauber, we liberate T cells from the semantic trap of immunity and suggest that the primary function of T cells is to prevent dedifferentiation that is, "…in a world in which necessity is represented by an inevitable disappearance of differentiation." 2 This way, T cells put strict limits on variations of host cells and prevent a natural tendency of people to develop tumors.
Unexpectedly, the first robust vindication for this proposal emerged from the widespread autoimmune adverse events in advanced melanoma patients receiving the checkpoint blocking anti-CTLA-4 antibody (ipilimumab) (13) as described below.
Ipilimumab clinical trials -Our alternative interpretation of severe, widespread autoimmune-related adverse events
The developers of the inhibitory anti-CTLA-4 antibody, ipilimumab, started with the premise that in an individual with no pathology other than cancer, most CTLA-4 expressing T-cells are either effector cells engaged in an anti-tumor response or regulatory T-cells actively opposing that response (14) . Therefore, a CTLA-4 blockade would then selectively target T cells involved in the anti-tumor immune response. Although ipilimumab improved survival in a minority of metastatic melanoma patients, the vast majority suffered autoimmune-related adverse events (irAEs In a study by Downey et al. (18) , all complete responders experienced high-grade irAEs.
These observations corroborate the idea of coupling autoimmunity and tumor immunity (15) .
We are inclined to suggest a cautious view that the widespread and dose-dependent irAEs of ipilimumab can be better explained by our one-signal T cell activation theory (11 Consistent with the hypothesis that defense against pathogens appeared later in evolution, epidemiological observations support the view that the immune system is far from being infallible against pathogens.
Before modern medicine, people succumbed to infections at much earlier age not living long enough to get cancer
The demographic transition from high to low mortality (38) occurred following the discovery of antibiotics and successful immunization programs. Before these medical achievements the likelihood of an individual dying prematurely from infectious diseases was as high as 40%.
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As Mukherjee emphasized, prior to the miracles of modern medicine, "people didn't live long enough to get cancer. Men and women were long consumed by tuberculosis, dropsy, cholera, smallpox, leprosy, plague, or pneumonia (39) ."
In contrast to the 40% death rate by infections, only one-third of humans are struck by cancer, mainly with advancing age (40) . Fortuitously, good supporting historical evidence is available in the Statistical Yearbook of Hungary from 1896 about all-causes and causespecific mortality. We created an interactive figure using the visualization tool Krona (41). 6 7 The data show that deaths due to infections were 27%, whereas deaths due to cancer were only 2%. It must be noted that the mortality rate of 27% from infectious diseases is a conservative estimate, since pneumonia, bronchitis, meningitis and encephalitis were not included therein in the infectious disease category. It is noteworthy that a similar difference 
Slow growing tumor cells induce tolerance
Carcinogenesis is a long-lasting step-by-step progression of early-stage lesions of cancer into frankly malignant cells. In addition, it is noteworthy that it takes as long as 12 years for cancer cells to reach a population size of 10 9 cells contained within ~0.5 cm 3 , weighing ~0.5 g (42) . Consistent with this, the average age of women with pre-invasive lesions was about 20 years lower than for those with invasive lesions. 12 The risk of cancer increases exponentially with age (43) . The risk of breast cancer, for example, increases from 1 in 400
at thirty years of age to 1 in 9 at seventy years of age. Age-incidence curves rise sharply above the age of 50 years and are informative about the dynamics of tumor progression, the straight line showing a fit with power 4.8 (44) .
The slow growth of tumor cells is consistent with Pardoll's suggestion that specific immune surveillance systems operate at early stages of tumorigenesis, whereas established tumors induce immune tolerance (45) . The latter phenomenon is explained by the discontinuity theory of immunity claiming that the speed of antigenic change determines T cell activation. That is, the elimination of target cells is induced by an antigenic discontinuity, following a sudden modification of molecular motifs with which T cells interact (46) .
The paradox of cancer appears not to be "why does it occur", but rather "why does it occur so infrequently" (47) . It perhaps bears repeating that in fact, most human malignant tumors are latent for many years and became 'old' by the time they are detectable clinically, when termed incipient cancer. Although two out of three humans never develop clinically detectable cancer (40) , most individuals with no apparent pathology, but having died of trauma, at autopsies were discovered to have been harboring unsuspected microscopic primary cancers (48) (49) . The risk of suffering any cancer before the age of 40 is ~2%, but by age 80 this risk increases to 50% (50) . For this so called tumor dormancy, it was suggested that cancer may be thought of as a chronic disease, which is kept in check by the patients' own immune system and physiological mechanisms (51).
8 See In this connexion hepatitis B and C virus (HBV, HCV) infections are good examples.
According to Guidotti and Chisari (52) , in the unlikely event of all the 10 8 HBV-specific CTL in the entire body entering the liver at the same time and all the 10 11 hepatocytes quite commonly infected, for every 1,000 infected hepatocytes, there would be only one specific CTL in the liver to cope with the infection. Obviously, 1:1000 ratio would be totally inadequate for cytotoxic mechanism alone. Nevertheless, the immune system of most infected patients clears the virus within a few weeks without serious liver disease. This fact indicates the contribution of non-cytopathic mechanisms. Similarly, this occurs in HCV infections as well (53).
The law of independent T cell activation is consistent with recent clinical observations
The consensus view still is that the immune system is a complex and powerful defense mechanism (54) . In order to keep this power under control T cell antigen receptor (TCR) input must be complemented by CD28 co-stimulation to promote interleukin-2 (IL-2)-dependent proliferation, as described by the classic "two-signal" model of T cell activation (55) . This is taken to mean that each cell requires the conjoint signals within it for these two receptors triggering activation to a state suitable for cell division (56) .
In contrast, the law of independence of T cell activation described by Gett and Hodgkin (57) states that the internal mechanisms that control the rate of division, the likelihood of surviving and the likelihood of undergoing a differentiation operate independently within a cell. In fact, the strength of a T cell response can be predicted by adding together the underlying signal components from the TCR, co-stimulatory receptors, and cytokines. This law resolved the co-stimulation paradox and provided a quantitative paradigm for therapeutically manipulating immune response strength (58) . Consequently, there is no need for an obligatory co-stimulus for the decisions between tolerance and activation. were able to stimulate the T cell system indirectly by blocking the CD28 antagonist CTLA-4 co-receptors. In these interactions T cell pathways responsible for immune down-regulation were interrupted resulting in a dose-dependent, unrestrained, pan-lymphocytic T cell activation. This then turned homeostasis into overt autoimmunity (60) (61), thereby provoking an autologous graft versus host-like disease (GVHD) with severe, life-threatening autoimmune side effects.
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The fallacy of the infectious disease vaccination model of cancer immune therapy
One of the greatest triumphs of medicine was the discovery of immunization against infectious diseases. Successful vaccination programs have been developed against 27 different diseases. Vaccination against smallpox, which killed 300 to 500 million people even in the 20 th century, enabled the infection to be declared eradicated from the world in 1980. 13 Following the success of vaccines against xenogeneic infectious diseases, the tacit assumption, historically, has been that host immunity should be protective against isogeneic cancer as well. Following the simple principle of logic, assuming that immunity should be successful to defeat cancer as well, we submit that this makes it a fallacy. It is useful to (IL-2)-dependent co-stimulation of T cell before tolerance will have generated (45).
Tolerance breakdown is required for eradication of isogeneic tumors
Conventional cancer immunotherapy trials conducted with the best available science resulted in anecdotal responses. It is generally acknowledged that immunotherapy of cancer has not quite fulfilled the great promise and hopes of conquering cancer losing credibility (64) . conditions then the immune system gets dysregulated mistaking pollen for pathogen reacts when it really should not. The prevalence of asthma is rising also in low and middle income countries as they adopt a more Western-type lifestyle. In China, for example, where 1.9
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10 billion tons of coal is burnt each year to meet the 70 to 75% of the energy needs, outdoor pollution is associated with more than 300,000 deaths and 20 million cases of respiratory illnesses annually. So far asthma has affected more than 300 million people worldwide and the incidence is rising (67) (68).
The consequences of prolonged overstimulation of the B-7/CD28 axis by drugs or pollutants are persuasive enough to consider a critical re-examination of the conventional two-signal theory, invoking an obligatory co-stimulus for T cell activation as described below.
THE ONE-SIGNAL MODEL -A PAINTING WITH BROAD BRUSH STROKES
Numerous receptor-mediated signals are delivered to T cells, governing their survival, differentiation and proliferation. For the sake of simplicity, only two positive and one negative signals are depicted in Figure 1 . (6) iatrogenic tolerance breakdown.
T cell survival
As already stated, the homeostatic coupled system functions via an internal dialogue between positively selected low affinity complementary T cells and host cells (10) (11).
Recognition of ubiquitous and constitutive self-antigens by complementary T cells not only reliably sustains natural tolerance preventing dedifferentiation, but also ensures attacking cells presenting non-self peptides (see below).
Tumor prevention (surveillance)
The success of multicellularity depends upon the evolution of mechanisms that are able to suppress the ability of virtually every cell in an organism with the information and the potential to propagate rapidly (50) . Rinkevich suggested that the immune system has developed as a surveillance machinery for nascent selfish cells stemming from a kin organism or from transformed cells within the organism of origin (3) . Protective mechanisms that evolved over millions of years are indeed capable to keep the incidence of cancer very low (~2%) during reproductive age (50) . It should, however, be noted that despite appearances, the mechanism of primary protection against cancer is different from primary protection against infections (see below).
We hypothesize that cancer protection is carried out via cognate (complementary)
TCR-MHC interactions (see Fig. 1 ) such that T cells keep the number of somatic cells constant. Paraphrasing Georg Klein (40) , it would appear that evolution may have exploited over expression of a relatively limited number of common resistance genes to nip in the bud the incipient cancerous foci. Such preventive protection is all the more important since cancer is a state in which the epigenome is allowed to have greater plasticity than it is supposed to have in normal somatic tissues. It was argued that this increased epigenetic plasticity allows for selection in response to the cellular environment for cellular growth advantage at the expense of the host (69).
Bakacs et al. Notwithstanding, cancer is virtually inevitable in complex, long-lived, multicellular organisms. Extrapolating from the risk of affliction with any cancer, practically everybody will have developed cancer as human lifetime approaches one-hundred years (see figure 4 in (50)). This is due to the fact that somatic mutations inevitably accumulate with time and capable to overcome the suppressive mechanisms.
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Defense against primary infections
The probability is greater that the presentation of foreign peptides decreases rather than increasing the affinity for interaction with the TCRs during primary infections (10) . While February 28  th 2016 13 producing plasma cells (71) . Specific T and B cell activation, proliferation and lysis of infected cells, therefore, obey the rules of the conventional two-signal model.
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Accidental autoimmune disease
During an infection, when infected host cells lose their complementary T c cell contact, autoreactive T c cells with high affinity for a self peptide-MHC complex may be generated randomly, albeit with a small probability. This is consistent with the observations that autoimmunity might be thought of as a by-product of the immune response to microbial infection (72). 
Conclusions
Immunotherapy trials conducted with the best available science so far have not quite fulfilled the great promise and hopes of conquering cancer. Most spontaneous tumors are a part of self, a unique invention of nature. Nearly all neoantigens represent "passenger" mutations that do not directly contribute to tumorigenesis. The autoimmune power of T cells unleashed by the blockade of immune checkpoints should be harnessed for curing cancer. Tacitly assuming that immunization, which was so dramatically successful overcoming xenogeneic infections, should also be successful against isogenic tumours to defeat cancer surely is a fallacy.
While we pointed out the pitfalls and drawbacks of ipilimumab, we also recognized its potentials that had remained undiscussed. We suggested extending the use of ipilimumab to eradicate minimal residual disease (MRD) following induction of complete remission by high dose chemotherapy and autologous stem cell transplantation, or following reduced intensity conditioning in preparation for allogeneic stem cell transplantation (SCT) using donor lymphocyte infusion (DLI) if indicated (21) . On the other hand, in patients with high tumor burden, the forces of the immune system liberated by the co-stimulatory anti-CTLA-4 
